SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001145443-04-000574
Filing Date
2004-04-12
Accepted
2004-04-12 12:01:33
Documents
5
Period of Report
2004-05-13
Effectiveness Date
2004-04-12

Document Format Files

Seq Description Document Type Size
1 d14390_def14a.htm DEF 14A 332122
3 GRAPHIC averywsig.jpg GRAPHIC 6130
4 GRAPHIC chart.jpg GRAPHIC 41845
5 GRAPHIC jbarriewig.jpg GRAPHIC 7310
6 GRAPHIC logo.jpg GRAPHIC 5644
  Complete submission text file 0001145443-04-000574.txt   395066
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 04727917
SIC: 2835 In Vitro & In Vivo Diagnostic Substances